“`html When you hear about artificial intelligence revolutionizing drug discovery, you probably picture gleaming labs, sophisticated algorithms churning through molecular data, and breakthroughs happening at lightning speed. It’s a compelling vision, one that has attracted billions in investment and fueled immense hype across the biotech landscape. Companies like Recursion Pharmaceuticals, Exscientia, and BenevolentAI have become ...